Usefulness of intraoperative determination of central lymph node metastasis by palpation in papillary thyroid cancer.

BACKGROUND: This study evaluated the usefulness of judgment of central lymph node (LN) metastasis by surgeon's palpation in papillary thyroid cancer.
METHODS: This study included 127 patients who underwent thyroidectomy and central compartment node dissection between October 2014 and February 2015. The criterion for suspicious LNs was hardness.
RESULTS: Of the 20.5% (28/127) of suspicious for metastatic LNs according to surgeon determination, 92.8% (26/28) were confirmed to be metastatic in the final pathological examinations. Metastatic LNs were found in 38 (38.3%) of 99 patients without suspicious LNs, 29 of whom (76.3%) had micrometastases. The sensitivity, specificity, and positive and negative predictive values for the determination of LN metastasis by a surgeon were 40.6%, 96.8%, 92.9%, and 61.6%, respectively.
CONCLUSION: Determination of central LN metastasis by a surgeon's palpation may be useful to evaluate LNs owing to the high specificity and positive predictive values, especially in macrometastasis or high-risk LN disease.

Introduction

The incidence of papillary thyroid carcinoma (PTC) has increased globally [1]. Although PTC has a much better prognosis than those of many other cancers, cervical lymph node (LN) metastasis occurs in 30%–80% cases and reportedly increases local recurrence rates [2,3].

Central compartment node dissection (CCND) allows accurate LN staging, reduces local recurrence by clearing metastatic LN, and has a good effect on survival [4]. However, the indication and optimal extent of LN dissection for PTC remain controversial (prophylactic vs. therapeutic, ipsilateral vs. bilateral) because the sensitivity of ultrasonography (USG) and computed tomography (CT) for central cervical LN metastasis in thyroid cancer is low, with poor diagnostic performance [5,6]. In addition, prophylactic CCND may increase morbidity including hypocalcemia and recurrent laryngeal nerve (RLN) palsy; thus, the clinical benefit of survival gained from CCND is unclear [7]. However, CCND performed by experienced, high-volume surgeons (>25 total thyroidectomies/year) have relatively lower postoperative morbidity rates within the acceptable range [8].

LN metastasis is one of the important criteria for determining the extent of surgery (lobectomy vs. total thyroidectomy, ipsilateral vs. bilateral CCND) in thyroid cancer. Total thyroidectomy is preferred to lobectomy if unilateral cancer has multiple central LN metastases, and bilateral CCND may be required rather than ipsilateral CCND. A study of central LN metastasis of unilateral cancer with clinically node-negative status in our institution reported that ipsilateral LN metastasis was the most important high-risk factor for predicting contralateral LN metastasis [9].

Intraoperative frozen biopsy is a useful method to determine the extent of surgery to minimize unnecessary bilateral CCND by confirming LN metastasis. Although frozen biopsy is available in tertiary hospitals with sufficient pathologist support, it is not a feasible option in most other hospitals. In addition, frozen biopsy leads to longer operation times and increases costs for examination; moreover, pathologist skills and efforts are important; thus, there are rarely false-negative results in frozen biopsy.

Therefore, our research team questioned whether inspection and palpation by the surgeon could confirm central LN metastasis and replace the need for frozen biopsy during surgery. Hence, this study aimed to evaluate the accuracy and usefulness of single-surgeon inspection and palpation to evaluate central LN metastasis and determine the extent of surgery.

Materials and methods

This study was approved by the Institutional Review Board (IRB) of the Kyungpook National University Chilgok Hospital (IRB No: 2020-04-008).

Since 2010, the author (WWK) has performed approximately 300–400 thyroid surgeries per year. To evaluate whether the metastasis can be judged by inspection and palpation, for approximately 2 months before starting the study, all LNs were examined using the same methods after CCND and frozen biopsy was performed to confirm the presence of metastasis in suspicious LNs. This study retrospectively included 127 consecutive patients who underwent thyroidectomy and CCND between October 2014 to February 2015. All patients were diagnosed with PTC based on fine-needle aspiration biopsy before surgery and clinically negative LN (nonspecific or considered to be benign) by physical examination and high-resolution USG. All USGs were performed by a well-trained thyroid surgeon or a radiologist specializing in thyroids. The exclusion criteria were benign or follicular neoplasm or other malignancy, previous thyroid operation, clinically positive LN (suspicious metastatic LN), or presence of central/lateral LN metastasis. Regarding the extent of CCND, ipsilateral CCND was performed for unilateral PTC measuring less than 1 cm with negative LN, while bilateral CCND was performed in PTC with bilateral involvement or metastasis in ipsilateral central LN or grossly extrathyroidal extension. Ipsilateral CCND included pretracheal, paratracheal, and prelaryngeal LNs. Micrometastasis was defined as a maximum metastatic focus size <0.2 cm, while ≥0.2 cm was defined as macrometastasis. According to the American Thyroid Association Guidelines, all involved LNs sized <0.2 cm and <5 metastatic LNs were classified as low-risk LN disease; whereas >5 metastatic LNs, macroscopic LN metastasis (clinical N1), and ≥3 cm metastatic LNs were considered high-risk LN disease. One specialized thyroid surgeon (WWK) examined each LN and assessed the metastasis after CCND by inspection and palpation. The surgeons divided the LNs into benign and suspicious metastatic groups and only the suspicious metastatic LNs were numbered. The results were confirmed by frozen or permanent biopsy. In the surgeon's experience, the critical criterion for suspicious metastatic LN was hardness (≥6 points out of 10) rather than enlargement or discoloration. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of intraoperative determinations by the surgeon were examined on basis of the final pathology results. All statistics were analyzed using IMB SPSS version 20.0 (IBM Corp., Armonk, NY, USA).

Results

The clinicopathologic results of the 127 patients are summarized in Table 1. A mean of 6.09±5.25 (range, 0–24) LNs was retrieved and a mean of 1.37±2.57 (range, 0–17) LNs were metastatic. LN metastases were present in 64 patients (50.4%), of whom 37 (57.8%) showed micrometastases, with a mean metastatic LN size of 0.28±0.24 cm (range, 0.1–1.2 cm). The intraoperative determinations and pathologic results of all patients are shown (Fig. 1). Twenty-eight patients (22.0%) had suspicious metastatic LNs based on the surgeon’s determination, and a total of 128 suspicious metastatic LNs were harvested. A mean of 0.33±0.8 (range, 0–5) suspicious metastatic LNs were removed per patient. Of these 28 patients, 26 (92.9%) were diagnosed with metastasis based on permanent pathologic examination (Fig. 1). Eighteen (69.2%) and eight patients (30.8%) had macrometastasis and micrometastasis, respectively. High-risk nodal disease was found in 20 (71.4%) of these patients, while low-risk LN disease was found in six patients (21.4%). Among 99 patients without suspicious metastatic LNs, 38 (38.4%) had metastasis, 29 (76.3%) had micrometastasis. All of these 29 patients had fewer than five micrometastases. Low-risk LN disease was found in 90 of the 99 patients (90.9%), including 61 patients without metastasis, while high-risk LN disease was observed in nine (9.1%) patients.

Table 1.

Clinicopathologic results of 127 patients

Characteristic	Value
Age (yr)	46.8±9.7 (25−71)
Sex (female:male)	107:20 (84.3:15.7)
Lobectomy:total thyroidectomy	68:59 (53.5:46.5)
Tumor size (cm)	0.83±0.6 (0.2−3.8)
PTMC	93 (73.2)
Extrathyroidal extension	64 (50.4)
Thyroiditis	50 (39.4)
Suspicious for metastatic LN determined by surgeon	28 (20.5)
Number removed from suspicious for metastatic LN	0.33±0.8 (0−5)
Frozen biopsy for suspicious LN	17 (13.4)
Number of retrieved LN	6.09±5.2 (0−24)
Number of metastatic LN	1.37±2.5 (0–17)
Metastatic LN size (cm)	0.28±0.24 (0.1−1.2)
Metastasis on LN	64 (50.4)
Micrometastasis on LN	37/64 (57.8)

Values are presented as mean±standard deviation (range) or number (%).

PTMC, papillary thyroid microcarcinoma; LN, lymph node.

Fig. 1.

Flowchart of lymph node (LN) assessment by palpation and pathology results of all 127 patients who underwent surgery.

The diagnostic accuracy of the determination of central LN metastasis by surgeon inspection and palpation is shown in Table 2, including a 40.6% sensitivity (26/64), 96.8% specificity (61/63), 92.9% PPV (26/28), and 61.6% NPV (61/99). A patient with thyroiditis is likely to have multiple reactive LNs. It is difficult to distinguish metastasis by palpation as thyroiditis is a complicated factor. Therefore, 77 patients without thyroiditis were re-examined (Table 3). Of these, 12 patients had suspicious LNs and all were diagnosed with metastasis upon final pathological examination. Of the 65 patients considered to have normal LNs, 23 (35.3%) had metastasis, with micrometastasis present in 18 patients (18/23, 78.2%). Furthermore, the 23 patients with false-negative biopsy results mostly had low-risk LN disease. In patients without thyroiditis, the results of central LN metastasis determined by the surgeon included 34.2% sensitivity (12/35), 100% specificity (42/42), 100% PPV (12/12), and 64.6% NPV (42/65). The false-negative, false-positive, and accuracy rates were 65.7%, 0%, and 70.1%, respectively. No recurrence was observed during the mean 61.2-month follow-up period (range, 58.5–64.1 months).

Table 2.

The diagnostic accuracy for determination of central lymph node (LN) metastasis by surgeon using inspection and palpation (n=127)

Variable	Permanent pathology after surgery
	Metastatic LN (+) (n=64)	Metastatic LN (–) (n=63)
Suspicious for metastatic LN determined by surgeon (n=28)	26 (92.9)	2 (7.1)
Normal LN determined by surgeon (n=99)	38 (38.4)	61 (61.6)

Values are presented as number (%).

Table 3.

The diagnostic accuracy for determination of central lymph node (LN) metastasis by surgeon in cases without thyroiditis (n=77)

Variable	Permanent pathology after surgery
	Metastatic LN (+) (n=35)	Metastatic LN (–) (n=42)
Suspicious for metastatic LN determined by surgeon (n=12)	12 (100)	0
Normal LN determined by surgeon (n=65)	23 (35.4)	42 (64.6)

Values are presented as number (%).

Discussion

The extent of adequate CCND for differentiated thyroid carcinoma remains controversial. CCND reportedly improves patient survival rates and reduces the risk of recurrence when clinical LN metastasis is apparent [10,11]. However, concrete evidence is lacking to show that prophylactic CCND increases the survival rate in patients with differentiated thyroid cancer [12,13]. Although prophylactic CCND may be considered in patients aged >45 years and with T3/4 tumors, bilateral/multi-focal tumor, and extrathyroidal extension, and is not currently recommended for patients with clinical N0, CCND has been reported to reduce postoperative recurrence rates and allow accurate nodal staging to establish postoperative management and follow-up strategies [14]. In addition, CCND has also been reported to lower thyroglobulin levels after surgery [15,16].

LN metastasis in PTC, including micrometastasis, is commonly observed in approximately 30%–80% patients and is not uncommon in patients with clinical N0 on preoperative examination. LN metastasis is an important risk factor that should not be overlooked as it reportedly increases local recurrence rates and the risk of death in patients aged ≥45 years [11]. The optimal treatment strategy is to accurately determine the central LN metastasis through preoperative examination, perform comprehensive CCND if LN metastasis is suspicious, decrease the recurrence rate, and improve the survival rate. In addition, it is essential to minimize complications such as hypocalcemia and RLN palsy by avoiding unnecessary bilateral CCND through appropriate CCND extent.

However, surgeons find it challenging to decide whether to perform prophylactic CCND and determine the extent of CCND (ipsilateral/bilateral). LN evaluation using cervical USG is highly dependent on the examiner, as the diagnostic rate of USG for central cervical LN metastasis is as low as 20%–30% and those of other radiological examinations such as CT, MRI, and positron emission tomography-CT are reported to be as low as 30%–40% [17,18].

Frozen biopsy during thyroid surgery is useful to diagnose ambiguous thyroid cancer, confirm LN metastasis, and determine parathyroid gland histology. It also provides useful information to determine surgery extent. In our previous study, ipsilateral LN metastasis was the most potent high-risk factor for contralateral LN metastasis, suggesting that bilateral LN involvement is likely in these cases [7]. Therefore, total thyroidectomy and bilateral CCND may be good treatment options for multiple ipsilateral LN metastases on frozen section biopsy in patients with unilateral PTC to reduce the local recurrence rate by excising hidden metastatic LNs. However, frozen section biopsies require a clinically experienced pathologist and additional staff, along with increased cost and a minimum of 20–30 additional minutes for intraoperative examination. While waiting for frozen biopsy results, patients continue under extended anesthesia; prolonged operation time may have negative effects, especially in patients with comorbidities.

We have noted hardness or infiltration as a feature of metastatic LN from experience [19]. If the LN was not hard and enlarged, it was more likely to be reactive LN due to thyroiditis, as metastatic LNs are hard even if small. Black-colored LNs are not highly associated with metastasis. Because benign reactive LNs can also become large or discolored, enlargement or discoloration is not a direct feature of metastatic LNs. Although the hardness criterion was fairly subjective, we considered hardness greater than that of rubber (score>6 of 10, where 10 is the hardest) to be suspicious. The more LNs surgeons palpate, the more clearly they could feel the difference. Benign LNs became softer when palpated while suspicious metastatic LNs remained firm even with continued palpation. As described in this study, surgeons can palpate and inspect all LNs after CCND and compare the results to the biopsy findings. The repetitive feedback will establish individual criteria based on the hardness for suspicious LNs.

In this study, it was difficult to distinguish between micrometastasis and benign LNs because the ratio of micrometastases was high and the metastatic LNs were small (mean size, 0.28±0.24 cm). Therefore, the sensitivity and NPV were low and surgeon inspection and palpation had limitations. However, metastatic LNs with macrometastasis or extranodal extension were easier to distinguish from benign LNs. Of the 38 patients with false-negative results (38.4%), 29 (76.3%) had micrometastasis and low-risk nodal disease. Therefore, the clinical significance of LN metastasis in false-negative cases may not be significant as it is likely to be low-risk LN disease. In cases with a strong belief of metastasis in the suspicious LN (large, hard, multiple LNs, or extranodal extension) by palpation, we recommend total thyroidectomy and both CCND.

Recently, extranodal extension has been reported as a high-risk factor associated with disease-free survival, cause-specific survival, recurrence, and metastasis [20,21]. It is the most important nodal risk factor as patients with extranodal extension are associated with disease progression showing high thyroglobulin, nodal persistence, and systemic disease. Two patients (both excluded from this study) who underwent modified radical neck dissection due to lateral LN metastasis during this period had LN metastasis with extranodal extension. All were suspected to be metastasis by the palpation method and all LNs biopsy results were confirmed to be metastases.

Approximately 40% of patients in this study had thyroiditis, with a large number of reactive LNs due to inflammatory reactions. Therefore, it is not easy to evaluate metastatic LNs by intraoperative palpation or preoperative USG in patients with thyroiditis. In this study, the sensitivity, specificity, PPV, and NPV of LN evaluation based on the surgeon’s inspection and palpation were not reliable or accurate in patients with thyroiditis. However, in those without thyroiditis, the specificity and PPV of evaluation by LN palpation were 100%. Therefore, LN evaluation using inspection and palpation may be useful in identifying metastasis in patients suspected of LN metastasis, especially in patients without thyroiditis.

Surgeon inspection and confirmation of each LN is helpful not only to assess whether metastatic LN is present but also to determine any unintentional removal of the parathyroid gland (incidental parathyroidectomy). It is important to reduce the incidence of permanent hypoparathyroidism by autotransplantation if unintended parathyroid removal is found during the inspection.

Our study has some limitations. First, there may be errors in the accuracy of the test because not all LNs were examined individually. Second, there is a limit to using judgment by palpation as an absolute criterion because it is difficult to establish objective criteria for hardness; thus, it requires subjective judgment. Third, LN evaluation by this method is difficult before CCND, thereby lowering the sensitivity. In this study, a single surgeon performed nodal palpation, and we did not assess interobserver variation in a blinded fashion. The determination of LNs by surgeon palpation may be helpful to some extent; however, it should be confined to an auxiliary diagnostic method due to some limitations.

The determination of central LN metastasis by surgeon’s inspection and palpation could be used to evaluate LNs owing to its high specificity and PPV, especially for macrometastasis or high-risk LN disease.